Membrane fusion, potential threats, and natural antiviral drugs of pseudorabies virus

• Published in: Veterinary research (Paris) 2023-05, Vol.54 (1), p.39-39, Article 39
• Main Authors: Ye, Ni, Feng, Wei, Fu, Tiantian, Tang, Deyuan, Zeng, Zhiyong, Wang, Bin
• Format: Article
• Language: English
• Subjects: Amino acids; Animals; antiviral; Antiviral agents; Antiviral Agents - pharmacology; Antiviral Agents - therapeutic use; Antiviral drugs; Aujeszky's disease; China; Drugs; Encephalitis; Epidemics; Genomes; Heparan sulfate; Herpes viruses; Herpesvirus 1, Suid; Hogs; human health; human infection; Humans; Infections; Life Sciences; Membrane Fusion; membrane fusion process; Nervous system; Oriental traditional medicine; Pork industry; Proteins; Pseudorabies; Pseudorabies virus; Review; Suid alphaherpesvirus 1; Swine; Swine Diseases - drug therapy; Swine Diseases - prevention & control; therapeutics; traditional Chinese medicine; Vaccines; Viral infections
• ISSN: 1297-9716; 0928-4249; 1297-9716
• DOI: 10.1186/s13567-023-01171-z

Pseudorabies virus (PrV) can infect several animals and causes severe economic losses in the swine industry. Recently, human encephalitis or endophthalmitis caused by PrV infection has been frequently reported in China. Thus, PrV can infect animals and is becoming a potential threat to human health. Although vaccines and drugs are the main strategies to prevent and treat PrV outbreaks, there is no specific drug, and the emergence of new PrV variants has reduced the effectiveness of classical vaccines. Therefore, it is challenging to eradicate PrV. In the present review, the membrane fusion process of PrV entering target cells, which is conducive to revealing new therapeutic and vaccine strategies for PrV, is presented and discussed. The current and potential PrV pathways of infection in humans are analyzed, and it is hypothesized that PrV may become a zoonotic agent. The efficacy of chemically synthesized drugs for treating PrV infections in animals and humans is unsatisfactory. In contrast, multiple extracts of traditional Chinese medicine (TCM) have shown anti-PRV activity, exerting its effects in different phases of the PrV life-cycle and suggesting that TCM compounds may have great potential against PrV. Overall, this review provides insights into developing effective anti-PrV drugs and emphasizes that human PrV infection should receive more attention.